111in-cp04
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2016 (NCT03246659)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 111-indium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03246659 | Phase 1 | Aug 31, 2016 | Erasmus University Rotterdam, INRASTES, NCSR Demokritos, Athens, Greece, Jagiellonian University, Medical University Innsbruck, NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland, University of Freiburg, University of Ljubljana, University of Pisa |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Erasmus University Rotterdam | Academic/Hospital | 1 | 0 | 1 | 2016 |
| INRASTES, NCSR Demokritos, Athens, Greece | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Jagiellonian University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Medical University Innsbruck | Academic/Hospital | 1 | 0 | 1 | 2016 |
| NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Freiburg | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Ljubljana | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Pisa | Academic/Hospital | 1 | 1 | 1 | 2016 |
8 organizations
Page 1 / 1